Publication:
Prevalence, characteristics, and impact of Adverse Events in 34 Madrid hospitals. The ESHMAD study.

dc.contributor.authorValencia-Martín, J L
dc.contributor.authorVicente-Guijarro, J
dc.contributor.authorSan Jose-Saras, D
dc.contributor.authorMoreno-Nunez, P
dc.contributor.authorPardo-Hernández, A
dc.contributor.authorAranaz-Andrés, J M
dc.contributor.authorESHMAD Director Group and external advisers
dc.date.accessioned2023-05-03T13:28:50Z
dc.date.available2023-05-03T13:28:50Z
dc.date.issued2022-07-31
dc.description.abstractAdverse Events (AE) are one of the main problems in healthcare. Therefore, many policies have been developed worldwide to mitigate their impact. The Patient Safety Incident Study in Hospitals in the Community of Madrid (ESHMAD) measures the results of them in the region. Cross-sectional study, conducted in May 2019, in hospitalised patients in 34 public hospitals using the Harvard Medical Practice Study methodology. A logistic regression model was carried out to study the association of the variables with the presence of AE, calibrated and adjusted by patient. A total of 9,975 patients were included, estimating a prevalence of AE of 11.9%. A higher risk of AE was observed in patients with surgical procedures (OR[CI95%]: 2.15[1.79 to 2.57], vs. absence), in Intensive Care Units (OR[CI95%]: 1.60[1.17 to 2.17], vs. Medical), and in hospitals of medium complexity (OR[CI95%]: 1.45[1.12 to 1.87], vs. low complexity). A 62.6% of AE increased the length of the stay or it was the cause of admission, and 46.9% of AE were considered preventable. In 11.5% of patients with AE, they had contributed to their death. The prevalence of AE remains similar to the previously estimated in studies developed with the same methodology. AE keep leading to longer hospital stays, contributing to patient's death, showing that it is necessary to put focus on patient safety again. A detailed analysis of these events has enabled the detection of specific areas for improvement according to the type of care, centre, and patient.
dc.identifier.doi10.1111/eci.13851
dc.identifier.essn1365-2362
dc.identifier.pmcPMC9787492
dc.identifier.pmid35909351
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787492/pdf
dc.identifier.unpaywallURLhttps://idus.us.es/bitstream/11441/141209/1/Prevalence...pdf
dc.identifier.urihttp://hdl.handle.net/10668/19948
dc.issue.number12
dc.journal.titleEuropean journal of clinical investigation
dc.journal.titleabbreviationEur J Clin Invest
dc.language.isoen
dc.organizationHospital Universitario Virgen del Rocío
dc.page.numbere13851
dc.pubmedtypeJournal Article
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titlePrevalence, characteristics, and impact of Adverse Events in 34 Madrid hospitals. The ESHMAD study.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number52
dspace.entity.typePublication

Files